678 results on '"Kench, James G"'
Search Results
2. Long-term ex situ normothermic perfusion of human split livers for more than 1 week
3. Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study
4. Looking beyond workforce parity: addressing gender inequity in pathology
5. Pathologist-Level Grading of Prostate Biopsies with Artificial Intelligence
6. African-specific molecular taxonomy of prostate cancer
7. Prognostic models to predict survival in patients with pancreatic cancer: a systematic review
8. The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer
9. Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer.
10. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
11. Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals
12. Does an Additional Bile Duct Flush With Low-viscosity Preservation Solution Reduce Bile Duct Injury? A Single-blinded Randomized Clinical Trial
13. Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios
14. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists
15. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
16. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
17. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
18. Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading
19. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus
20. Whole genomes redefine the mutational landscape of pancreatic cancer
21. The Delay of Arterialization After Initial Portal Reperfusion More Than Warm Ischemia Time May Determine Ischemic-type Biliary Injury
22. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR)
23. p53 nuclear accumulation as an early indicator of lethal prostate cancer
24. Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting
25. Surveillance after prostate focal therapy
26. Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study
27. Histological Assessment of the Bile Duct before Liver Transplantation: Does the Bile Duct Injury Score Predict Biliary Strictures?
28. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma.
29. Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma
30. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer
31. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists
32. Hypermutation In Pancreatic Cancer
33. Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol
34. Data from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition
35. Data from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
36. Supplementary Figure 1 from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
37. Supplementary Figure 4 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
38. Supplementary Figure 3 from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
39. Supplementary Figure 2 from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
40. Supplementary Figure 5 from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
41. Supplementary Figure 1 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
42. Supplementary Table 2 from Comparative Biomarker Expression and RNA Integrity in Biospecimens Derived from Radical Retropubic and Robot-Assisted Laparoscopic Prostatectomies
43. Supplementary Table 2 from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
44. Supplementary Tables 1-3 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
45. Supplementary Figure 4 from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
46. Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition
47. Supplementary Figure Legend from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
48. Data from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
49. Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition
50. Supplementary Table 1 from Comparative Biomarker Expression and RNA Integrity in Biospecimens Derived from Radical Retropubic and Robot-Assisted Laparoscopic Prostatectomies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.